Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 1 of 15, showing 5 Applications out of 75 total, starting on record 1, ending on 5

# Protocol No Study Title Investigator(s) & Site(s) Application Status

1.

ECCT/21/06/15   Therapeutic Efficacy Study
    Efficacy of Artemether Lumefantrine (AL) and Dihydroartemisinin-Piperaquine (DHP) for the treatment of uncomplicated Plasmodium falciparum malaria in Siaya and Bungoma counties, Kenya.   
Principal Investigator(s)
1. Dr. Sarah-Blythe Ballard
2. Dr. Willis Akhwale
3. Dr. Grace Ikahu
4. Dr. George Githuka
5. Dr. Dickson Mtungu Mwakangalu
6. Dr. Elvis Omondi Oyugi
7. Hellen Gatakaa
8. Regina Jepkosgei Kandie
9. Dr. Fredrick Ouma Odhiambo
Site(s) in Kenya
1. Mahonge Health Center (Bung\'oma county)
2. Kaluo Health Center (Siaya county)
 
Trial Status (not set!)
Protocol Date 01-03-2020
View

2.

ECCT/21/05/07   CoVPN 3008
    Multi-Center, Randomized, Efficacy Study of COVID-19 mRNA Vaccine in Regions with SARS-CoV-2 Variants of Concern   
Principal Investigator(s)
1. Grace Mboya Mugure
Site(s) in Kenya
1. KEMRI CGHR Kisumu Clinical Research Site (Kisumu county)
 
Trial Status (not set!)
Protocol Date 16-05-2021
View

3.

ECCT/21/05/02   BFTAF Elderly Switch Study
    Switching virally suppressed HIV-1 infected elderly adults (age ≥ 60 years) without prior confirmed virological failure from current anti-retroviral regimen to bictegravir, emtricitabine and tenofovir alafenamide (B/F/TAF)   
Principal Investigator(s)
1. Loice Achieng Ombajo
Site(s) in Kenya
1. Kenyatta National Hospital (Nairobi City county)
2. Jaramogi Oginga Odinga Teaching and Referral Hospital (Kisumu county)
 
Trial Status (not set!)
Protocol Date 16-12-2020
View

4.

ECCT/21/03/03   PrEP My Way
    A Novel PrEP Delivery System to Meet the Needs of Young African Women   
Principal Investigator(s)
1. Prof. Elizabet Ann Bukusi
Site(s) in Kenya
Kisumu
 
Trial Status Recruiting
Protocol Date 29-10-2019
View

5.

ECCT/21/03/07   CHIMES
    AN OPEN-LABEL, MULTICENTER STUDY TO ASSESS DISEASE ACTIVITY AND BIOMARKERS OF NEURONAL DAMAGE IN MINORITY PATIENTS WITH RELAPSING MULTIPLE SCLEROSIS RECEIVING TREATMENT WITH OCRELIZUMAB   
Principal Investigator(s)
1. Mansoor Saleh
Site(s) in Kenya
Aga Khan University, Nairobi
 
Trial Status Recruiting
Protocol Date 16-12-2020
View